Tuesday, May 10th, 2016

WiseGuyReports.com adds “Cystic Fibrosis - Pipeline Review, H1 2016” new report to its research database. The report Spread across 380 pages with tables and figures.

The report “Cystic Fibrosis - Pipeline Review, H1 2016” provides comprehensive information on the therapeutics under development for Cystic Fibrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Cystic Fibrosis and features dormant and discontinued projects.

Complete Report Details Available at https://www.wiseguyreports.com/reports/cystic-fibrosis-pipeline-review-h1-2016-fibrosis-pipeline-review-h1-2016 .

Companies mentioned in this report are:

Actelion Ltd, Akari Therapeutics, Plc, Alaxia SAS, AlgiPharma AS, AmpliPhi Biosciences Corporation, Arcturus Therapeutics, Inc, Aridis Pharmaceuticals LLC, AstraZeneca Plc, Bayer AG, Boehringer Ingelheim GmbH, Calista Therapeutics, Inc., Carolus Therapeutics, Inc., Celtaxsys, Inc., Chiesi Farmaceutici SpA, Cilian AG, Concert Pharmaceuticals, Inc., Corbus pharmaceuticals, Inc., CSA Biotechnologies LLC, Cyclacel Pharmaceuticals, Inc., DiscoveryBiomed, Inc., Editas Medicine, Inc., Errant Gene Therapeutics, LLC, Galapagos NV, GlaxoSmithKline Plc, Grifols, S.A., Grupo Praxis Pharmaceutical SA, Horizon Pharma Plc, Insmed Incorporated, Invion Limited, JHL Biotech, Inc., Kamada Ltd.,m La Jolla Pharmaceutical Company, Lamellar Biomedical Ltd, Laurent Pharmaceuticals Inc., Mast Therapeutics, Inc., Merck & Co., Inc., Microbion Corporation, Mucokinetica Ltd., NanoBio Corporation, Nivalis Therapeutics, Inc., Nostrum Pharmaceuticals, LLC, Novabiotics Limited, Novartis AG, OSE Pharma SA, Parion Sciences, Inc., Pfizer Inc., Pharmaxis Limited, PhaseBio Pharmaceuticals, Inc., Polyphor Ltd., Progenra, Inc., ProMetic Life Sciences Inc., ProQR Therapeutics N.V., Protalix BioTherapeutics, Inc., Proteostasis Therapeutics, Inc., PTC Therapeutics, Inc., Pulmatrix, Inc., Raptor Pharmaceutical Corp., ReveraGen BioPharma, Inc., Savara Inc., Serendex Pharmaceuticals A/S, Shionogi & Co., Ltd., Shire Plc, Synovo GmbH, TGV-Laboratories, The International Biotechnology Center (IBC) Generium, Verona Pharma Plc, Vertex Pharmaceuticals , ncorporated, Xenetic Biosciences (UK) Limited, Zambon Company S.p.A.

Inquire more about this report at https://www.wiseguyreports.com/enquiry/cystic-fibrosis-pipeline-review-h1-2016-fibrosis-pipeline-review-h1-2016 .


- The report provides a snapshot of the global therapeutic landscape of Cystic Fibrosis 
- The report reviews pipeline therapeutics for Cystic Fibrosis by companies and universities/research institutes based on information derived from company and industry-specific sources 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report reviews key players involved Cystic Fibrosis therapeutics and enlists all their major and minor projects 
- The report assesses Cystic Fibrosis therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report summarizes all the dormant and discontinued pipeline projects 
- The report reviews latest news related to pipeline therapeutics for Cystic Fibrosis

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Cystic Fibrosis 
- Identify potential new clients or partners in the target demographic 
- Develop strategic initiatives by understanding the focus areas of leading companies 
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics 
- Devise corrective measures for pipeline projects by understanding Cystic Fibrosis pipeline depth and focus of Indication therapeutics 
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope 
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

Get a sample copy at https://www.wiseguyreports.com/sample-request/cystic-fibrosis-pipeline-review-h1-2016-fibrosis-pipeline-review-h1-2016 .

Contact Profile


Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

Our Market Research Reports and Consulting Services 

Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories. The Wise Guy Reports team prides itself in being the chosen source for market research reports, report customizations services, and other ancillary services such as a Newsletter service and corporate service for large organizations.

Hundreds of large and small organizations across virtually every industry sector worldwide are currently reaping rich dividends from the sharp insights provided by market research reports sourced through Wise Guy Reports. 

Gaining an insight into emerging trends, opportunities and potential threats is key to long-term sustenance in a competitive environment. The handpicked collection of market research reports on Wise Guy Reports is centred on this proven principle.

Norah Trent
P: +44 208 133 9349
M: +1 646 845 9349
W: www.wiseguyreports.com/


Cystic Fibrosis Hepatitis Therapeutics, Cystic Fibrosis Hepatitis Therapeutics Market, Cystic Fibrosis Hepatitis Therapeutics Market Trends, Cystic Fibrosis Hepatitis Therapeutics Industry Trends, Cystic Fibrosis Hepatitis Therapeutics Market Share




More Formats

View QR Code